维普中文期刊产品整合服务
53篇 您的检索式:作者名="HENGSTLER JG"
    题名 作者 年代 出处 被引量
1Contribution of c-erbB-2 and Topoisomerase Ⅱα to Chemoresistance in ovarian cancer 显示文摘Hengstler JG Lange J Kett A 1999Cancer Res1999,59,13:1
2contribution of c-erbB-2 and to poisomerase II alpha to chemoresistance in ovarian cancer显示文摘Hengstler JG Lange J Kett A 1999Caner Res1999,59,13:1
3Control of oxidative stress by the Keapl-Nrf2 pathway 显示文摘Stewart JD Hengstler JG Bolt HM 2011Arch Toxicol2011,485,4:1
4contribution of c-erbB-2 and topoisomerase II alpha to chemoresistance in ovarian cancer显示文摘Hengstler JG lange J Kett A 1999cancer Res1999,59,13:1
5Cryopreserved primany hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction显示文摘Hengstler JG Utesch D Steinberg P 2000Drug Metab Review2000,32,1:1
6Genotoxic effects of the herbicides alachlor, atrazine, pendimethaline, and simazine in mammalian cells 显示文摘Dunkelberg H Fuchs J Hengstler JG 1994Bull Environ Contain Toxicol1994,52,4:1
7Tumor ceil specific toxicity of Inula helenium extracts显示文摘Dorn DC Alexenizer M Hengstler JG 2006Phytother Res2006,20,11:1
8Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction显示文摘Hengstler JG Utesch D Steinberg P 2000Drug Metab Rev2000,32,1:1
9Polymorphisms of N-acetyltransferase, glutathione S-transferase, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility显示文摘Hengstler JG Arand M Herrero ME 1998Recent Results Cancer Res1998,154,1:1
10Inhibition of doxorubicin-in-duced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells显示文摘Bezler M Hengstler JG Ullrich A 2012Mol Oncol2012,6,5:1
11Metallothionein expression in ovarian cancer in relation to histopatho!ogical parameters and molecular markers of prognosis 显示文摘Hengstler JG Pilch H Schmidt M 2001Int J Cancer2001,95,2:1
12Alternative methods to safety studies in experimental ani-mals:role in the risk assessment of chemicals under the new Eu-ropean Chemicals Legislation(REACH)显示文摘Lilienblum W Dekant W Foth H Gebel T Hengstler JG Kahl R 2008Arch Toxicol2008,82,4:1
13Failure in drug development:the role of inhibition and induction of cytochrome P450enzymes显示文摘Hengstler JG Bolt HM 2008Arch Toxicol2008,82,10:1
14c-kit expression in adenocarcinomas of the lung 显示文摘Micke P Hengstler JG Albrecht H 2004Tumor Biol2004,25,:1
15Contribution of c-erbB-2 and topoisomerase Ⅱ to chemoresistance in ovarian cancer显示文摘HENGSTLER JG LANGE J KETT A 1999Cancer Research1999,59,:1
16Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel显示文摘 Gorycki PD Hengstler JG 1999Chem Biol Interact1999,121,:1
17Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction显示文摘 Utesch D Steinberg P 2000Drug Metab Rev2000,32,:1
18Interspecies differences in cancer susceptibility and toxicity 显示文摘Hengstler JG Van der Burg B Steinberg P 1999Drug Metab Rev1999,31,4:1
19Present status of the application of cryopreserved he- patocytes in the evaluation of xenobiotics: consensus of an international expert panel显示文摘Li AP Gorycki PD Hengstler JG Kedderis GL Koebe HG Rahmani R 1999Chem Biol Interact1999,121,1:1
20Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction 显示文摘Hengstler JG Utesch D Steinberg P Platt KL Diener B Ringel M 2000Drug Metab Rev2000,32,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费